Skip to main content
Cuorips Inc. logo

Cuorips Inc. - Investor Relations & Filings

Listed IPO Jun 2023
Ticker · 4894 ISIN · JP3266030000 T Manufacturing
Open in API
Filings indexed 45 across all filing types
Latest filing 2024-05-13 Regulatory Filings
Country JP Japan
Listing T 4894 · 1 venue

About Cuorips Inc.

https://cuorips.co.jp/en/

Cuorips Inc. is a regenerative medicine company that originated as a spin-off from Osaka University. The company specializes in the research, development, and commercialization of cellular and tissue-based products derived from induced pluripotent stem (iPS) cells. Its primary product is a cardiac myocyte sheet, a novel therapy developed for treating severe heart failure. This cardiac tissue sheet, created from iPS cells, is designed to be grafted onto a patient's heart to restore function. In addition to its proprietary product pipeline, Cuorips provides contract services for the development and manufacturing of cell processing products, contributing to the advancement of medical care through cutting-edge technology.

Recent filings

Filing Released Lang Actions
2024年３月期 決算短信〔日本基準〕（連結）
Regulatory Filings
2024-05-13 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document text contains the header "第３四半期報告書" (Third Quarter Report) and specifies the period covered: "第８期第３四半期（自 2023年10月１日 至 2023年12月31日）". It also includes confirmation statements by the CEO and CFO regarding the appropriateness of the filing content based on financial instruments laws, submitted to the Kanto Local Finance Bureau. This structure strongly indicates a comprehensive quarterly financial report, which aligns with the definition of an Interim / Quarterly Report (IR). The document length is very short (606 chars), but the content is the substance of the report confirmation/filing itself, not merely an announcement of its publication, thus classifying it as the report type rather than RPA or RNS.
2024-02-13 Japanese
四半期報告書－第8期第3四半期(2023/10/01－2023/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Cuorips Inc. covering the third quarter of the fiscal year ending 2024. It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as notes to the financial statements and management analysis. This fits the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-02-13 Japanese
2024年３月期 第３四半期決算短信〔日本基準〕（連結）
Regulatory Filings
2024-02-13 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-8 of the Financial Instruments and Exchange Act of Japan. This is a mandatory internal control certification that accompanies a Quarterly Report (Shihanki Hokokusho). Since the document is a formal regulatory filing confirming the accuracy of the quarterly financial statements and is not the quarterly report itself, it falls under the general regulatory filing category.
2023-11-10 Japanese
四半期報告書－第8期第2四半期(2023/07/01－2023/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Cuorips Inc. with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements (balance sheet, income statement, cash flow statement) for the second quarter of the fiscal year ending March 31, 2024. As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. H1 2024
2023-11-10 Japanese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.